The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Jul 13, 2026
Snapshot (as of Jul 13, 2026): Quest Diagnostics Incorporated (DGX) pays a $3.32 annual dividend ($0.86 quarterly), yielding 1.60% at $207.44/share. Next ex-dividend date 2026-07-08. 20+ consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.60%
Annual Dividend: $3.32 per share
Payout Ratio: 34.9%
Ex-Dividend Date: 2026-07-08
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 23
Quest Diagnostics Incorporated dividend investors are looking at a company that processes diagnostic testing for patients, clinicians, hospitals, and health plans across the U.S. and internationally, operating under brands including AmeriPath, ExamOne, and Quanum. DGX currently pays a 1.6% dividend yield. The trailing annual dividend rate is $3.32 per share, paid quarterly, with the next ex-dividend date on July 8, 2026. A beta of 0.571 points to below-average price volatility, which suits investors who prioritize steady dividend growth over maximum current income.
Quest Diagnostics Incorporated pays out 34.9% of earnings as dividends, a payout ratio classified as conservative (below 40%). That level of earnings retention gives DGX meaningful room to sustain and grow its dividend, supported by a broad client base spanning patients, health plans, employers, and hospitals that generates recurring demand for diagnostic testing services. Quest Diagnostics Incorporated dividend safety benefits from this low payout floor, though any material shift in reimbursement rates or healthcare utilization patterns could pressure future earnings available for distribution.
Quest Diagnostics Incorporated dividend history shows a CAGR of 15.9% per year from 2011 to 2025. The per-share dividend grew from $0.40 to $3.15 over that period (2026 data is partial and excluded from this calculation). The smallest annual increase in the window was 4.2% in 2020, which sets a floor for what slower growth looks like even in a difficult year.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +6.6% | $2.60 (2022) | $3.15 (2025) |
| 5-Year | +7.3% | $2.21 (2020) | $3.15 (2025) |
| 10-Year | +7.9% | $1.47 (2015) | $3.15 (2025) |
DGX fits growth-and-income investors who want a rising dividend stream from a healthcare diagnostics business and are willing to accept a low current yield in exchange for above-average growth. At 1.6%, the yield is classified as low (below 2%), and it sits above the 5-year average of 1.34%, meaning the current entry point offers slightly more income than the historical norm. The 34.9% payout ratio keeps the dividend well-covered. What an investor gains here is a 20-year streak of consecutive increases and a 15.9% CAGR. The trade-off is a yield that will not satisfy investors who need meaningful current income from their portfolio.
| Payment Date | Amount per Share |
|---|---|
| 2026-07-08 | $0.8600 |
| 2026-04-06 | $0.8600 |
| 2026-01-13 | $0.8000 |
| 2025-10-03 | $0.8000 |
| 2025-07-07 | $0.8000 |
| 2025-04-07 | $0.8000 |
| 2025-01-14 | $0.7500 |
| 2024-10-04 | $0.7500 |
| 2024-07-08 | $0.7500 |
| 2024-04-05 | $0.7500 |
| Year | Total Dividends |
|---|---|
| 2026 | $2.5200 |
| 2025 | $3.1500 |
| 2024 | $2.9600 |
| 2023 | $2.7900 |
| 2022 | $2.6000 |
Project income from DGX with the DGX dividend calculator or track your full portfolio with the dividend tracker.